Camp4 director sells 10 CAMP shares at $4.50

Camp4 Therapeutics Corp (CAMP) director Andrew J. Schwab reported a small sale of 10 shares of common stock on 2026-08-24 at $4.50 per share.

Rhea-AI Filing Summary

Camp4 Therapeutics Corp (CAMP) director Andrew J. Schwab reported a small sale of 10 shares of common stock on 2026-08-24 at $4.50 per share. The shares are held indirectly through 5AM Ventures VI, L.P., with Schwab reporting shared voting and investment power through his role at its general partner and disclaiming beneficial ownership except for his pecuniary interest.

Following this transaction, entities associated with Schwab reported indirect holdings of 2,433,270 shares via 5AM Ventures VI, L.P., 2,941,176 shares via 5AM Ventures VII, L.P., and 302,770 shares via 5AM Opportunities II, L.P. The filing does not indicate use of a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 10 shares

Net Sell 3 txns

Insider Schwab Andrew J.

Role Director

Sold 10 shs ($45.00)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	10	$4.50	$45.00
holding	Common Stock F2	--	--	--
holding	Common Stock F3	--	--	--

Holdings After Transaction: Common Stock — 2,433,270 shares (Indirect, By 5AM Ventures VI, L.P.); Common Stock — 2,941,176 shares (Indirect, By 5AM Ventures VII, L.P.); Common Stock — 302,770 shares (Indirect, By 5AM Opportunities II, L.P.)

Footnotes (3)

1. F1. The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. The Reporting Person is a managing member of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
2. F2. The shares are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
3. F3. The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. The Reporting Person is a managing member of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II GP. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Key Figures

Shares sold: 10 shares of Common Stock Sale price per share: $4.5000 per share Indirect holdings via 5AM Ventures VI, L.P.: 2,433,270 shares of Common Stock +2 more

5 metrics

Shares sold 10 shares of Common Stock Sale on 2026-08-24 reported by director Andrew J. Schwab

Sale price per share $4.5000 per share Price for the 10-share sale of Camp4 Therapeutics Corp common stock

Indirect holdings via 5AM Ventures VI, L.P. 2,433,270 shares of Common Stock Total shares indirectly held after the reported transaction

Indirect holdings via 5AM Ventures VII, L.P. 2,941,176 shares of Common Stock Holding entry as of 2026-08-24

Indirect holdings via 5AM Opportunities II, L.P. 302,770 shares of Common Stock Holding entry as of 2026-08-24

Key Terms

indirect, beneficial ownership, pecuniary interest, shared voting and investment power

4 terms

indirect financial

"The transaction was reported as an indirect sale through 5AM Ventures VI, L.P."

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership of such shares except"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"disclaims beneficial ownership of such shares except to the extent of his pecuniary interest"

shared voting and investment power financial

"may be deemed to have shared voting and investment power over the shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CAMP director Andrew J. Schwab report on this Form 4?

Andrew J. Schwab reported a sale of 10 shares of Camp4 Therapeutics Corp common stock on 2026-08-24 at a price of $4.50 per share. The transaction was reported as an indirect sale through 5AM Ventures VI, L.P.

How many CAMP shares did entities associated with Andrew J. Schwab hold after this transaction?

After the reported sale, entities associated with Andrew J. Schwab held 2,433,270 shares via 5AM Ventures VI, L.P., 2,941,176 shares via 5AM Ventures VII, L.P., and 302,770 shares via 5AM Opportunities II, L.P., all reported as indirect holdings.

Was the August 24, 2026 CAMP stock sale under a Rule 10b5-1 trading plan?

No. The Form 4 for Camp4 Therapeutics Corp indicates the Rule 10b5-1 checkbox as not checked, and the footnotes do not describe the 10-share sale on 2026-08-24 as being made under a Rule 10b5-1 trading plan.

How is Andrew J. Schwab’s ownership in CAMP characterized in the Form 4 footnotes?

The footnotes state that shares are directly held by 5AM Ventures VI, VII, and Opportunities II, with Schwab as a managing member of their general partners. He may be deemed to share voting and investment power but disclaims beneficial ownership except for his pecuniary interest.

Is the reported CAMP stock transaction a direct or indirect holding for Andrew J. Schwab?

The reported 10-share sale of Camp4 Therapeutics Corp common stock is classified as an indirect transaction, with ownership noted as “By 5AM Ventures VI, L.P.” and Schwab’s role described through the general partner entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 04:58 PM EDT Accepted by SEC EDGAR 08/26/2026 - 04:57 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schwab Andrew J.

(Last) (First) (Middle)

C/O 5AM VENTURE MANAGEMENT, LLC

4 EMBARCADERO CENTER, SUITE 3110

(Street)

SAN FRANCISCO CALIFORNIA 94111

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Camp4 Therapeutics Corp [ CAMP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/24/2026		S		10	D	$4.5	2,433,270	I	By 5AM Ventures VI, L.P.(1)
Common Stock								2,941,176	I	By 5AM Ventures VII, L.P.(2)
Common Stock								302,770	I	By 5AM Opportunities II, L.P.(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. The Reporting Person is a managing member of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

2. The shares are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

3. The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. The Reporting Person is a managing member of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II GP. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

	/s/ Andrew J. Schwab	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)